Femhrt Dosage

Your femhrt dosage will be based on several factors, such as how you respond to the drug, other medical conditions you have, and the severity of your menopause symptoms. The drug comes in tablet form and is taken once a day. It is available in two strengths, either of which can be used to treat menopausal symptoms or prevent osteoporosis. However, it is generally recommended to start with the lower dosage.

 

Femhrt Dosage: An Introduction

The dose of femhrt® (norethindrone acetate/ethinyl estradiol) your healthcare provider recommends will vary, depending on a number of factors, including:
 
  • How you respond to femhrt
  • The severity of your menopause symptoms
  • Other medical conditions you may have.
     
As always, do not adjust your femhrt dose unless your healthcare provider specifically instructs you to do so.
 

Femhrt Dosing for Menopause Symptoms or Osteoporosis Prevention

The drug comes in the following strengths:
 
  • femhrt 0.5/2.5 -- 0.5 mg of norethindrone acetate and 2.5 mcg (0.0025 mg) of ethinyl estradiol per tablet
  • femhrt 1/5 -- 1 mg of norethindrone acetate and 5 mcg (0.005 mg) of ethinyl estradiol per tablet.
     
Although either femhrt dosage can be used for menopausal symptoms (such as hot flashes or night sweats) or for osteoporosis prevention, the lower dose should typically be tried first.
 
When taking femhrt, you will not have a regular monthly period, although you may experience bleeding and spotting, especially at first. This usually goes away over time. If you experience persistent or bothersome bleeding or spotting while on femhrt, let your healthcare provider know.
 
If you are using femhrt for menopausal symptoms, your healthcare provider should periodically re-evaluate your need to take femhrt (every three to six months), and you should take it only as long as necessary.
 
(Femhrt Dosage Continued: Page 2)
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;